Search

everythinglearnresearchcommunity

for

Search:↓

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

AI improves vascular surgery by enhancing precision and safety, but doctors make final decisions.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

The model accurately detects alopecia areata with 84.3% accuracy.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia significantly affects men, often causing hair loss in eyebrows, beard, and sideburns.

Higher FABP4 levels may indicate more severe alopecia areata.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Upadacitinib effectively treats severe alopecia areata and is safe.

Stem cell factor and certain proteins help melanocytes from hair follicles move and attach better, aiding vitiligo repigmentation.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

The JCCP's Premises Standards aim to make non-surgical cosmetic treatments safer and higher quality.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Increased sunscreen use may be linked to frontal fibrosing alopecia in Hispanic females.

UVFD helps detect hair follicles in alopecia areata better than traditional methods.

Understanding cellular interactions in VCA may lead to better treatments and reduce rejection.

Early diagnosis of Alopecia Frontal Fibrosante is crucial for effective treatment.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.